German Larrain is a Cardiology physician affiliated with Aspirus. OpenAlex indexes 24 publications with 665 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
500 Wind Ridge Dr
Wausau, WI 544014173
Telephone
715-847-2611Provider last certified this registry record 10 Jan 2023.
Clinical trials
- Safety and Efficacy of Low Dose Hypertonic Saline Solution and High Dose Furosemide for Congestive Heart Failure
Sponsor: Aspirus Heart and Vascular Institute-Research and Education
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Penumbra, Inc.Program year20257 payments
- Abbott LaboratoriesProgram year202520 payments
- Boston Scientific CorporationProgram year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.7%Beta blocker18%Metoprolol Succinate51%Carvedilol30%Metoprolol Tartrate13%Bisoprolol Fumarate2%Atenolol2%Sotalol1%Toprol Xl1%Part D<11 patientsStatin17.4%Atorvastatin Calcium59%Rosuvastatin Calcium33%Simvastatin4%Pravastatin Sodium3%Lovastatin1%Part D<11 patients+ 20 more classes in this area
Blood & clotting
13.1%Factor Xa inhibitor8.5%Eliquis80%Xarelto20%Part D≥183 patientsP2Y12 inhibitor2.9%Clopidogrel100%Part D≥115 patients+ 1 more class in this area
Metabolism & gastrointestinal
5.2%Potassium supplement2.4%Potassium Chloride89%Klor-Con M2011%Part D≥78 patientsSGLT2 inhibitor2%Jardiance92%Farxiga8%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System
JACC: Cardiovascular Interventions
2017 - Objective diagnosis and surgical management deferred in osteochondroma of mandibular condyle. Regional Hospital of Iquique – chile
International Journal of Oral and Maxillofacial Surgery
2013
Similar KOLs
Other experts from the same institution or the same specialty.
Andrew Beaumont, MD, PhD
Aspirus
Sarah Hostetler, MD
Aspirus
Ronald Miles, MD
Aspirus
Agnieszka Thompson, MD
Aspirus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”